Table 1 Body composition parameters at diagnosis and clinicopathological characteristics of 153 patients
|  | Mean ± standard deviation (range) | Number (%) |
|---|---|---|
Age at diagnosis, year | 55.83 ± 13.17 |  |
BMI, kg/m2 | 23.57 ± 4.21 |  |
Visceral fat area, cm2 | 85.52 ± 67.53 (6.36 - 407.00) |  |
Subcutaneous fat area, cm2 | 141.85 ± 64.71 (27.10 - 356.00) |  |
Total fat area, cm2 | 227.37 ± 122.64 (27.10 - 356.00) |  |
Skeletal muscle area, cm2 | 101.99 ± 16.35 (66.00 - 162.00) |  |
Skeletal muscle attenuation | 42.42 ± 9.27 (15.30 - 59.00) |  |
Skeletal muscle index (SMI), cm2/m2 | 41.53 ± 6.20 (2711.00 - 64.00) |  |
Visceral FMR | 0.83 ± 0.59 (0.08 - 3.23) |  |
Total FMR | 2.22 ± 1.08 (0.41 - 6.74) |  |
Age at diagnosis | ||
 <60 |  | 92 (60.1) |
 ≥60 |  | 61 (39.9) |
DM/HTN | ||
 No |  | 105 (68.6) |
 DM or HTN |  | 48 (31.4) |
Menopause | ||
 No |  | 55 (35.9) |
 Yes |  | 98 (64.1) |
BMI | ||
 <25 |  | 102 (66.7) |
 ≥25 |  | 51 (33.3) |
Cell type | ||
 Serous |  | 100 (65.4) |
 Non-serous |  | 53 (34.6) |
First-line therapy strategy | ||
 PDS |  | 135 (88.2) |
 NAC |  | 18 (11.8) |
Surgical optimality | ||
 Optimal |  | 115 (75.2) |
 Suboptimal |  | 38 (24.8) |
FIGO stage | ||
 1 |  | 49 (32.0) |
 2 |  | 8 (5.2) |
 3 |  | 71 (46.4) |
 4 |  | 25 (16.4) |
Chemoresponse | ||
 Sensitive |  | 112 (73.2) |
 Resistant |  | 20 (13.1) |
 Unknown |  | 7 (4.6) |
Recur | ||
 No |  | 75 (49.0) |
 Yes |  | 65 (42.5) |
 Unknown |  | 13 (8.5) |
SMI | ||
 <38.7 |  | 51 (33.3) |
 ≥38.7 |  | 102 (66.7) |